Sfoglia per AUTORE
D'AGOSTINO M
Collezione AOU Città della Salute di Torino

  

Items : 53

Impact of daratumumab on collection and engraftment in multiple myeloma patients undergoing hematopoietic stem cell mobilization with G-CSF plus on-demand plerixafor. in Bone marrow transplantation / Bone Marrow Transplant. 2025 Jan;60(1):79-82. doi: 10.1038/s41409-024-02432-x. Epub 2024 Oct 4.
2025
AOU Città della Salute di Torino

Bringhen S; Santoro A; Bruno B; Lorenzi M; Francisci T; Benevolo G; De Philippis C; Mannina D; Larocca A; Taurino D; Oliva S; D'agostino M; Mariotti J; Mercadante S; Gay F; Sarina B; Casson A; Garibaldi B; Bertuglia G; Mina R; Bramanti S;

M-protein-related necrobiotic granuloma in a multiple myeloma patient treated with daratumumab, lenalidomide and dexamethasone. in British journal of haematology / Br J Haematol. 2025 Jan;206(1):16-17. doi: 10.1111/bjh.19887. Epub 2024 Nov 14.
2025
AOU Città della Salute di Torino

D'Agostino M; Impalà GA; Bruno B; Bringhen S; Bertuglia G;

Overview of 1q abnormalities in multiple myeloma: scientific opinions from Italian experts. in Annals of hematology / Ann Hematol. 2025 Feb 13. doi: 10.1007/s00277-025-06212-5.
2025
ASL Vercelli
AOU Città della Salute di Torino

Ria R; Mina R; Mele G; Liberatore C; Furlan A; Fazio F; Derudas D; Mangiacavalli S; De Paoli L; Martello M; D'Agostino M; Zamagni E;

Comprehensive molecular profiling of multiple myeloma identifies refined copy number and expression subtypes. in Nature genetics / Nat Genet. 2024 Sep;56(9):1878-1889. doi: 10.1038/s41588-024-01853-0. Epub 2024 Aug 19.
2024
AOU Città della Salute di Torino

Craig D; Rogers J; DeRome M; Toone M; McBride K; Zaugg B; Donnelly A; Kidd P; Stumph J; Collison K; Gamella M; D'Agostino M; Kirchhoff M; Rohrer DC; Livermore B; Blanski A; Tassone E; Stephenson K; Reiman R; McDonald J; Kyman S; Helland A; Boateng M; Cuyugan L; Adkins JR; Yellapantula V; Washington M; Kurdoglu A; Turner B; et alii...

Allocation and validation of the second revision of the International Staging System in the ICARIA-MM and IKEMA studies. in Blood cancer journal / Blood Cancer J. 2024 Nov 28;14(1):209. doi: 10.1038/s41408-024-01149-w.
2024
AOU Città della Salute di Torino

Richardson PG; Perrot A; Mikhael J; Martin T; Beksac M; Spicka I; Capra M; D'Agostino M; Sonneveld P; Bisht K; Fukao T; Zhang R; Tada K; Tekle C; Macé S; Klippel Z; van de Velde H; Moreau P;

2024
AOU Alessandria
AOU Città della Salute di Torino

Bruno B; Zamagni E; Stefanoni P; Palmieri S; Liberati AM; Monaco F; Annibali O; Galieni P; Garzia M; Olivero M; Rogers J; Ruggeri M; Pescosta N; Pisani F; Tosi P; Pascarella A; Pietrantuono G; Arigoni M; De Sabbata G; Bertamini L; Belotti A; Rota-Scalabrini D; D'Agostino M; Calogero RA; Boccadoro M; Musto P; Gay F;

Update and European consensus on a patient-centered core outcome set for multiple myeloma in clinical practice and research. in Haematologica / Haematologica. 2024 Jun 1;109(6):1956-1959. doi: 10.3324/haematol.2023.284282.
2024
AOU Città della Salute di Torino

Oerlemans S; De Rooij BH; Bennink C; Bullinger L; Broijl A; D'Agostino M; Laane E; Lupo-Stanghellini MT; Perrot A; Wester R; Cursaru V; Scheurer H; Vesseur J; Dalal M; Sen R; Stamm T; Ludwig H; Sonneveld P;

Navigating High-Risk and Ultrahigh-Risk Multiple Myeloma: Challenges and Emerging Strategies. in American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting / Am Soc Clin Oncol Educ Book. 2024 Jun;44(3):e433520. doi: 10.1200/EDBK_433520.
2024
AOU Città della Salute di Torino

Rees MJ; D'Agostino M; Leypoldt LB; Kumar S; Weisel KC; Gay F;

Genomic and immune determinants of resistance to daratumumab-based therapy in relapsed refractory multiple myeloma. in Blood cancer journal / Blood Cancer J. 2024 Jul 19;14(1):117. doi: 10.1038/s41408-024-01096-6.
2024
AOU Città della Salute di Torino

Ziccheddu B; Giannotta C; D'Agostino M; Bertuglia G; Saraci E; Oliva S; Genuardi E; Papadimitriou M; Diamond B; Corradini P; Coffey D; Landgren O; Bolli N; Bruno B; Boccadoro M; Massaia M; Maura F; Larocca A;

Predictors of unsustained measurable residual disease negativity in patients with multiple myeloma. in Blood / Blood. 2024 Feb 15;143(7):592-596. doi: 10.1182/blood.2023022080.
2024
AOU Città della Salute di Torino

Paris L; Zambello R; Mancuso K; Gamberi B; Palmas AD; Gozzetti A; Cellini C; Ballanti S; Velluti C; Vincelli ID; Ronconi S; Pavone V; Grasso M; Ledda A; Oliva S; Corradini P; Morè S; Belotti A; Rota-Scalabrini D; Bertuglia G; D'Agostino M; Petrucci MT; Bruno B; Musto P; Gay F;

[How to optimize Audit&Feedback: experience from the EASY-NET programme]. in Epidemiologia e prevenzione / Epidemiol Prev. 2023 Nov-Dec;47(6):379-390. doi: 10.19191/EP23.6.A664.074.
2023
AOU Città della Salute di Torino

Acampora A; Angioletti C; D'Agostino M; Deroma L; Tullio A; Pagano E; Ciccone G; Marchesini G; Grilli R; Bonomi A; Marenzi G; Giusti A; Venturella R; Ciurleo R; Bramanti P; Davoli M; Agabiti N;

Prospective evaluation of minimal residual disease in the phase II FORTE trial: a head-to-head comparison between multiparameter flow cytometry and next-generation sequencing. in EClinicalMedicine / EClinicalMedicine. 2023 Jun 9;60:102016. doi: 10.1016/j.eclinm.2023.102016. eCollection 2023 Jun.
2023
AOU Città della Salute di Torino

Oliva S; Genuardi E; Paris L; D'Agostino M; Rogers J; Rota-Scalabrini D; Jacob AP; Patriarca F; Luppi M; Bertazzoni P; Velluti C; Capra A; Saraci E; Rossi M; Allegra A; Mina R; Gentile M; Kirsch IR; Belotti A; Cavo M; Bruno B; Musto P; Boccadoro M; Zamagni E; Gay F;

2023
AOU Città della Salute di Torino

Zamagni E; Oliva S; Gay F; Capra A; Rota-Scalabrini D; D'Agostino M; Belotti A; Galli M; Racca M; Zambello R; Gamberi B; Albano D; Bertamini L; Versari A; Grasso M; Sgherza N; Priola C; Fioritoni F; Patriarca F; De Cicco G; Villanova T; Pascarella A; Zucchetta P; Tacchetti P; Fanti S; Mancuso K; Barbato S; Boccadoro M; Musto P; et alii...

Immune Reconstitution and Vaccinations in Multiple Myeloma: A Report From the 19th International Myeloma Society Annual Workshop. in Clinical lymphoma, myeloma & leukemia / Clin Lymphoma Myeloma Leuk. 2023 Jun;23(6):413-419. doi: 10.1016/j.clml.2023.03.009. Epub 2023 Mar 2
2023
AOU Città della Salute di Torino

Dhodapkar MV; Avigan DE; Ludwig H; Jagannath S; Parekh S; D'Agostino M; van de Donk NWCJ; Neri P; Terpos E; Raje NS;

Lysin (K)-specific demethylase 1 inhibition enhances proteasome inhibitor response and overcomes drug resistance in multiple myeloma. in Experimental hematology & oncology / Exp Hematol Oncol. 2023 Aug 10;12(1):71. doi: 10.1186/s40164-023-00434-x.
2023
AOU Città della Salute di Torino

Bandini C; Mereu E; Paradzik T; Labrador M; Maccagno M; Cumerlato M; Oreglia F; Prever L; Manicardi V; Taiana E; Ronchetti D; D'Agostino M; Gay F; Larocca A; Besse L; Merlo GR; Hirsch E; Ciarrocchi A; Inghirami G; Neri A; Piva R;

Editorial: Risk factors in multiple myeloma identified before and during treatment: are we ready to personalize treatment? in Frontiers in oncology / Front Oncol. 2023 Jul 31;13:1247808. doi: 10.3389/fonc.2023.1247808. eCollection 2023.
2023
AOU Città della Salute di Torino

Terragna C; van Duin M; D'Agostino M;

Management of psoriatic arthritis: a consensus opinion by expert rheumatologists. in Frontiers in medicine / Front Med (Lausanne). 2023 Nov 30;10:1327931. doi: 10.3389/fmed.2023.1327931. eCollection 2023.
2023
AOU Città della Salute di Torino

Salvarani C; Rossini M; Ramonda R; Peluso R; Montecucco C; Lubrano E; Iannone F; Laganà B; Iagnocco A; Guggino G; Gremese E; Govoni M; Giacomelli R; Gabini M; Gerli R; Fusaro E; Franceschini F; Epis OM; Ferrucci MG; Dejaco C; Dagna L; D'Agostino MA; Ciccia F; Caso F; Cauli A; Carlino G; Cantini F; Caporali RF; Bianchi G; et alii...

Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY Project. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2022 Oct 10;40(29):3406-3418. doi: 10.1200/JCO.21.02614. Epub 2022 May 23.
2022
AOU Città della Salute di Torino

Cook G; Larocca A; Hernández Rivas JM; Goldschmidt H; Kaiser MF; Cavo M; Zweegman S; Gay F; Dürig J; Mai EK; Capra A; Castellani G; Bonello F; van der Holt B; Salwender H; Bladé Creixenti J; Rocchi S; van de Donk NWCJ; Jackson G; Dall'Olio D; Mateos MV; Zamagni E; Waage A; Bertsch U; Lahuerta JJ; Wester R; Cairns DA; D'Agostino M; San-Miguel JF; et alii...

Normalization of the Immunological Microenvironment and Sustained Minimal Residual Disease Negativity: Do We Need Both for Long-Term Control of Multiple Myeloma? in International journal of molecular sciences / Int J Mol Sci. 2022 Dec 14;23(24):15879. doi: 10.3390/ijms232415879.
2022
AOU Città della Salute di Torino

Bertuglia G; Cani L; Larocca A; Gay F; D'Agostino M;

Risk Stratification Before and During Treatment in Newly Diagnosed Multiple Myeloma: From Clinical Trials to the Real-World Setting. in Frontiers in oncology / Front Oncol. 2022 Mar 9;12:830922. doi: 10.3389/fonc.2022.830922. eCollection 2022.
2022
AOU Città della Salute di Torino

Bonello F; Cani L; D'Agostino M;

Early Spondyloarthritis Clinic: Organizational Improvements in the Patient Journey. in Frontiers in medicine / Front Med (Lausanne). 2022 May 24;9:833139. doi: 10.3389/fmed.2022.833139. eCollection 2022.
2022
AO Ordine Mauriziano
AOU Città della Salute di Torino

Ferri S; Tirri E; Scarpa R; Selmi C; Sarzi Puttini P; Russo R; Padula AA; Pagano Mariano G; Lubrano E; Lomater C; Guggino G; Gremese E; Giacomelli R; Fusaro E; Franceschini F; Erre GL; D'Agostino MA; Dagna L; Ciccia F; Caminiti M; Baldissera E; Atzeni F; Afeltra A; D'Angelo S; Iannone F;

Immune dysfunctions affecting bone marrow V?9V?2 T cells in multiple myeloma: Role of immune checkpoints and disease status. in Frontiers in immunology / Front Immunol. 2022 Dec 20;13:1073227. doi: 10.3389/fimmu.2022.1073227. eCollection 2022.
2022
AOU Città della Salute di Torino

Grasso M; Larocca A; Kopecka J; D'Agostino M; Avonto I; Grimaldi D; Tripoli E; Castella B; Giannotta C; Riganti C; Massaia M;

2021
AOU Alessandria
AOU Città della Salute di Torino

Tacchetti P; Corradini P; Caravita di Toritto T; Patriarca F; Pompa A; Monaco F; Cellini C; Rota-Scalabrini D; Antonioli E; Bernardini A; Giuliani N; Galli M; Marasca R; Tosi P; Benevolo G; Capra A; Cascavilla N; Offidani M; Gaidano G; D'Agostino M; Bonello F; Larocca A; Boccadoro M; Bringhen S;

Minimal residual disease assessment by multiparameter flow cytometry in transplant-eligible myeloma in the EMN02/HOVON 95 MM trial. in Blood cancer journal / Blood Cancer J. 2021 Jun 3;11(6):106. doi: 10.1038/s41408-021-00498-0.
2021
AOU Città della Salute di Torino

Oliva S; Bruinink DHO; Rihova L; D'Agostino M; Pantani L; Capra A; van der Holt B; Troia R; Petrucci MT; Villanova T; Vsianska P; Jugooa R; Brandt-Hagens C; Gilestro M; Offidani M; Ribolla R; Galli M; Hajek R; Gay F; Cavo M; Omedé P; van der Velden VHJ; Boccadoro M; Sonneveld P;

A longitudinal analysis of chromosomal abnormalities in disease progression from MGUS/SMM to newly diagnosed and relapsed multiple myeloma. in Annals of hematology / Ann Hematol. 2021 Feb;100(2):437-443. doi: 10.1007/s00277-020-04384-w. Epub 2021 Jan 3.
2021
AOU Città della Salute di Torino

Oliva S; De Paoli L; Ruggeri M; Caltagirone S; Troia R; Oddolo D; D'Agostino M; Gilestro M; Mina R; Saraci E; Margiotta Casaluci G; Genuardi E; Bringhen S; Boccadoro M; Omedé P;

2021
AO Cuneo
AOU Città della Salute di Torino

Petrucci MT; Gamberi B; Zambello R; Palmas A; de Fabritiis P; Aquino S; Giuliani N; Capra A; D'Agostino M; Patriarca F; Spadano A; Cea M; Ballanti S; Ledda A; Grasso M; Zamagni E; Offidani M; Galli M; Belotti A; Bertamini L; Rota-Scalabrini D; Musto P; Gay F; Corradini P; Cavo M; Boccadoro M;

European Myeloma Network perspective on CAR T-Cell therapies for multiple myeloma. in Haematologica / Haematologica. 2021 Aug 1;106(8):2054-2065. doi: 10.3324/haematol.2020.276402.
2021
AOU Città della Salute di Torino

Bruno B; Wäsch R; Engelhardt M; Gay F; Giaccone L; D'Agostino M; Rodríguez-Lobato LG; Danhof S; Gagelmann N; Kröger N; Popat R; Van de Donk NWCJ; Terpos E; Dimopoulos MA; Sonneveld P; Einsele H; Boccadoro M;

2021
AOU Città della Salute di Torino

Rocchi S; Mancuso K; Pantani L; Tacchetti P; Barbato S; Gozzetti A; Cea M; Morè S; D'Agostino M; Tosi P; Antonioli E; De Stefano V; Petrucci MT; Rivolti E; Dozza L; Cavo M; Rizzello I; De Cicco G; Fusco A; Zamagni E;

Octogenarian newly diagnosed multiple myeloma patients without geriatric impairments: the role of age >80 in the IMWG frailty score. in Blood cancer journal / Blood Cancer J. 2021 Apr 12;11(4):73. doi: 10.1038/s41408-021-00464-w.
2021
ASL Torino 4
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Hájek R; Sonneveld P; Boccadoro M; Musto P; Guglielmelli T; Di Raimondo F; Corradini P; Aitoro G; Benevolo G; Giuliani N; Patriarca F; Bonello F; de Fabritiis P; Innao V; Zambello R; Cascavilla N; Derudas D; Capra A; Petrucci MT; Gaidano G; Offidani M; Liberati AM; Larocca A; D'Agostino M; Bringhen S;

MRD Assessment in Multiple Myeloma: Progress and Challenges. in Current hematologic malignancy reports / Curr Hematol Malig Rep. 2021 Apr;16(2):162-171. doi: 10.1007/s11899-021-00633-5. Epub 2021 May 5.
2021
AOU Città della Salute di Torino

Bertamini L; D'Agostino M; Gay F;

Early Relapse Risk in Patients with Newly Diagnosed Multiple Myeloma Characterized by Next-generation Sequencing. in Clinical cancer research : an official journal of the American Association for Cancer Research / Clin Cancer Res. 2020 Sep 15;26(18):4832-4841. doi: 10.1158/1078-0432.CCR-20-0951. Epub 2020 Jul 2.
2020
AOU Città della Salute di Torino

D'Agostino M; Zaccaria GM; Ziccheddu B; Rustad EH; Genuardi E; Capra A; Oliva S; Auclair D; Yesil J; Colucci P; Keats JJ; Gambella M; Bringhen S; Larocca A; Boccadoro M; Bolli N; Maura F; Gay F; D'Agostino M; Zaccaria GM; Ziccheddu B; Rustad EH; Genuardi E; Capra A; Oliva S; Auclair D; Yesil J; Colucci P; Keats JJ; et alii...

Monoclonal Antibodies to Treat Multiple Myeloma: A Dream Come True. in International journal of molecular sciences / Int J Mol Sci. 2020 Nov 1;21(21):8192. doi: 10.3390/ijms21218192.
2020
AOU Città della Salute di Torino

D'Agostino M; Innorcia S; Boccadoro M; Bringhen S;

Anti-CD38 monoclonal antibodies in multiple myeloma: another cook in the kitchen? in The Lancet. Haematology / Lancet Haematol. 2020 May;7(5):e355-e357. doi: 10.1016/S2352-3026(19)30254-6. Epub 2020 Mar 11.
2020
AOU Città della Salute di Torino

Gay F; Mina R; D'Agostino M;

Lenalidomide-based induction and maintenance in elderly newly diagnosed multiple myeloma patients: updated results of the EMN01 randomized trial. in Haematologica / Haematologica. 2020 Jul;105(7):1937-1947. doi: 10.3324/haematol.2019.226407. Epub 2019 Oct 3.
2020
ASL Torino 4
AOU Città della Salute di Torino

Boccadoro M; Larocca A; Falco P; Hájek R; Palumbo A; Marasca R; Cellini C; Petrucci MT; Tosi P; Gentile M; Baldini L; Santoro A; Aquino S; Poggiu M; Pavone V; Gazzera G; De Rosa L; Grasso M; Rota-Scalabrini D; Pezzatti S; Spada S; Ballanti S; Pescosta N; Paris L; D'Agostino M; Bringhen S;

Anti-BCMA CAR T-cell therapy in multiple myeloma: can we do better? in Leukemia / Leukemia. 2020 Jan;34(1):21-34. doi: 10.1038/s41375-019-0669-4. Epub 2019 Nov 28.
2020
AOU Città della Salute di Torino

Raje N; D'Agostino M;

The Role of Monoclonal Antibodies in the First-Line Treatment of Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma. in Pharmaceuticals (Basel, Switzerland) / Pharmaceuticals (Basel). 2020 Dec 29;14(1):20. doi: 10.3390/ph14010020.
2020
AO Cuneo
AOU Città della Salute di Torino

Bringhen S; Boccadoro M; Castellino A; Celeghini I; Grasso M; D'Agostino M; Bonello F;

Clinical Applications and Future Directions of Minimal Residual Disease Testing in Multiple Myeloma. in Frontiers in oncology / Front Oncol. 2020 Jan 31;10:1. doi: 10.3389/fonc.2020.00001. eCollection 2020.
2020
AOU Città della Salute di Torino

Oliva S; D'Agostino M; Boccadoro M; Larocca A;

The OMERACT Stepwise Approach to Select and Develop Imaging Outcome Measurement Instruments: The Musculoskeletal Ultrasound Example. in The Journal of rheumatology / J Rheumatol. 2019 Oct;46(10):1394-1400. doi: 10.3899/jrheum.181158. Epub 2019 Mar 15.
2019
AOU Città della Salute di Torino

D'Agostino MA; Boers M; Beaton DE; Maxwell LJ; Conaghan PG; Wakefield RJ; Iagnocco A; Bruyn GAW; Keen HI; Naredo E; Terslev L;

2019
AOU Città della Salute di Torino

Boccadoro M; Dimopoulos MA; Caers J; Gramatzki M; Auner HW; Ludwig H; Driessen C; Cavo M; Goldschmidt H; Terpos E; Zweegman S; Offidani M; Larocca A; Gay F; Wäsch R; Ferri C; D'Agostino M; Milan A; Bringhen S; Einsele H; Sonneveld P; Engelhardt M;

Pursuing a Curative Approach in Multiple Myeloma: A Review of New Therapeutic Strategies. in Cancers / Cancers (Basel). 2019 Dec 13;11(12):2015. doi: 10.3390/cancers11122015.
2019
AOU Città della Salute di Torino

D'Agostino M; Bertamini L; Oliva S; Boccadoro M; Gay F;

Clinical and Pharmacologic Features of Monoclonal Antibodies and Checkpoint Blockade Therapy in Multiple Myeloma. in Current medicinal chemistry / Curr Med Chem. 2019;26(32):5968-5981. doi: 10.2174/0929867325666180514114806.
2019
AOU Città della Salute di Torino

D'Agostino M; Gazzera G; Cetani G; Bringhen S; Boccadoro M; Gay F;

Determining treatment intensity in elderly patients with multiple myeloma. in Expert review of anticancer therapy / Expert Rev Anticancer Ther. 2018 Sep;18(9):917-930. doi: 10.1080/14737140.2018.1496823. Epub 2018 Ju
2018
AOU Città della Salute di Torino

Salvini M; D'Agostino M; Bonello F; Boccadoro M; Bringhen S; Salvini M; D'Agostino M; Bonello F; Boccadoro M; Bringhen S;

Gentle yet effective combination therapy with novel agents in elderly multiple myeloma patients. in British journal of haematology / Br J Haematol. 2018 Jul;182(2):165-167. doi: 10.1111/bjh.15260. Epub 2018 May 6.
2018
AOU Città della Salute di Torino

Boccadoro M; D'Agostino M; Larocca A; Larocca A; D'Agostino M; Boccadoro M;

CD38 as an immunotherapeutic target in multiple myeloma. in Expert opinion on biological therapy / Expert Opin Biol Ther. 2018 Dec;18(12):1209-1221. doi: 10.1080/14712598.2018.1544240. Epub 2018 Nov
2018
AOU Città della Salute di Torino

Bonello F; D'Agostino M; Moscvin M; Cerrato C; Boccadoro M; Gay F; Bonello F; D'Agostino M; Moscvin M; Cerrato C; Boccadoro M; Gay F;

Continuous therapy in standard- and high-risk newly-diagnosed multiple myeloma: A pooled analysis of 2 phase III trials. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2018 Dec;132:9-16. doi: 10.1016/j.critrevonc.2018.09.008. Epub 2018 Sep 14.
2018
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
AOU Novara

Gay F; Nagler A; Boccadoro M; Montefusco V; Palumbo A; Ribolla R; Siniscalchi A; Patriarca F; Pezzatti S; De Sabbata G; Di Renzo N; Rizzi R; Gamberi B; Baldini L; Guglielmelli T; Gilestro M; Catalano L; Marcatti M; Spada S; Petrucci MT; Ria R; Offidani M; De Paoli L; Conticello C; D'Agostino M;

Patient-centered practice in elderly myeloma patients: an overview and consensus from the European Myeloma Network (EMN). in Leukemia / Leukemia. 2018 Aug;32(8):1697-1712. doi: 10.1038/s41375-018-0142-9. Epub 2018 Apr 25.
2018
AOU Città della Salute di Torino

Einsele H; Boccadoro M; Dimopoulos MA; Offidani M; Gramatzki M; Auner HW; Caers J; Bringhen S; Ludwig H; Straka C; Cavo M; Gay F; Goldschmidt H; Scheubeck S; D'Agostino M; Wäsch R; Terpos E; Zweegman S; Dold SM; Larocca A; Sonneveld P; Engelhardt M; Larocca A; Dold SM; Zweegman S; Terpos E; Wäsch R; D'Agostino M; Scheubeck S; et alii...

Phase 1/2 study of weekly carfilzomib, cyclophosphamide, dexamethasone in newly diagnosed transplant-ineligible myeloma. in Leukemia / Leukemia. 2018 Apr;32(4):979-985. doi: 10.1038/leu.2017.327. Epub 2017 Nov 16.
2018
AOU Città della Salute di Torino
AOU Novara

Boccadoro M; Sonneveld P; Corradini P; Palumbo A; Gaidano G; Ballanti S; Petrucci MT; Offidani M; Musto P; De Angelis C; Esma F; Muccio VE; Liberati AM; Galieni P; Grammatico S; Montefusco V; De Paoli L; D'Agostino M; Bringhen S;

Promises and Pitfalls in the Use of PD-1/PD-L1 Inhibitors in Multiple Myeloma. in Frontiers in immunology / Front Immunol. 2018 Nov 27;9:2749. doi: 10.3389/fimmu.2018.02749. eCollection 2018.
2018
AOU Città della Salute di Torino

Gay F; Boccadoro M; D'Agostino M; Troia R; Oliva S; Oliva S; Troia R; D'Agostino M; Boccadoro M; Gay F;

Novel investigational drugs active as single agents in multiple myeloma. in Expert opinion on investigational drugs / Expert Opin Investig Drugs. 2017 Jun;26(6):699-711. doi: 10.1080/13543784.2017.1324571. Epub 2017 Ma
2017
AOU Città della Salute di Torino

D'Agostino M; Salvini M; Palumbo A; Larocca A; Gay F;

Plasma cell leukemia: update on biology and therapy. in Leukemia & lymphoma / Leuk Lymphoma. 2017 Jul;58(7):1538-1547. doi: 10.1080/10428194.2016.1250263. Epub 2016 Nov 6.
2017
AOU Città della Salute di Torino

Palumbo A; Gay F; Cerrato C; D'Agostino M; Mina R;

Novel Immunotherapies for Multiple Myeloma. in Current hematologic malignancy reports / Curr Hematol Malig Rep. 2017 Aug;12(4):344-357. doi: 10.1007/s11899-017-0397-7.
2017
AOU Città della Salute di Torino

D'Agostino M; Boccadoro M; Smith EL;

Immuno-oncologic Approaches: CAR-T Cells and Checkpoint Inhibitors. in Clinical lymphoma, myeloma & leukemia / Clin Lymphoma Myeloma Leuk. 2017 Aug;17(8):471-478. doi: 10.1016/j.clml.2017.06.014. Epub 2017 Jun 1
2017
AOU Città della Salute di Torino

Gay F; D'Agostino M; Giaccone L; Genuardi M; Festuccia M; Boccadoro M; Bruno B; Gay F; D'Agostino M; Giaccone L; Genuardi M; Festuccia M; Boccadoro M; Bruno B;

Moving Toward a Tailored Therapy in Multiple Myeloma. in Journal of oncology practice / J Oncol Pract. 2016 Apr;12(4):293-4. doi: 10.1200/JOP.2016.011627.
2016
AOU Città della Salute di Torino

D'Agostino M; Palumbo A;